Bennet, Burr, Hatch Applaud First FDA Approval of Breakthrough Therapy Drug
Senators Authored 'Breakthrough' Provision in 2012 FDA Reform Law
Nov 04, 2013
U.S. Senators Michael Bennet (D-CO), Richard Burr (R-NC), and Orrin Hatch (R-UT) welcomed the U.S. Food and Drug Administration’s (FDA) first approval of a cancer-fighting drug that had been granted a breakthrough therapy designation, thanks to a provision that the Senators successfully included in last year’s FDA Safet...